Home › Trial NCT01198158
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
- Trial IDNCT01198158
- StatusTerminated
- PhasePhase 3
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment77
- Start date2010-09-15
- ConditionsClear Cell Renal Cell Carcinoma · Recurrent Renal Cell Carcinoma · Stage III Renal Cell Cancer AJCC v7 · Stage IV Renal Cell Cancer AJCC v7
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.